Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Emma Caroline Materne, M.D.

Concepts (70)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Emma Materne's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Emma Materne has written about over time.
Isoleucine, 1 publications between 2015 and 2015, average publication date January 2015. Taq Polymerase, 1 publications between 2015 and 2015, average publication date January 2015. Adenoviridae Infections, 1 publications between 2016 and 2016, average publication date May 2016. Eye Infections, Viral, 1 publications between 2016 and 2016, average publication date May 2016. Adenoviruses, Human, 1 publications between 2018 and 2018, average publication date June 2018. Rec A Recombinases, 1 publications between 2018 and 2018, average publication date June 2018. Dynamin II, 1 publications between 2019 and 2019, average publication date January 2019. Virus Internalization, 1 publications between 2019 and 2019, average publication date January 2019. CD8-Positive T-Lymphocytes, 1 publications between 2020 and 2020, average publication date November 2020. Cytomegalovirus, 1 publications between 2020 and 2020, average publication date November 2020. Cytomegalovirus Infections, 1 publications between 2020 and 2020, average publication date November 2020. Epitopes, T-Lymphocyte, 1 publications between 2020 and 2020, average publication date November 2020. Immune Evasion, 1 publications between 2020 and 2020, average publication date November 2020. Pregnancy Complications, Infectious, 1 publications between 2020 and 2020, average publication date November 2020. Azathioprine, 1 publications between 2023 and 2023, average publication date October 2023. Immunosuppressive Agents, 1 publications between 2023 and 2023, average publication date October 2023. Lupus Erythematosus, Systemic, 1 publications between 2023 and 2023, average publication date October 2023. Methotrexate, 1 publications between 2023 and 2023, average publication date October 2023. Immunologic Deficiency Syndromes, 1 publications between 2024 and 2024, average publication date March 2024. Immunophenotyping, 1 publications between 2024 and 2024, average publication date March 2024.

To see the data from this visualization as text, click here.
Materne's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.